Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.23 USD | +1.69% | +6.01% | -14.03% |
Sales 2024 | 1,604B 10.27B 14.06B | Sales 2025 * | 1,676B 10.73B 14.69B | Capitalization | 2,859B 18.31B 25.07B |
---|---|---|---|---|---|
Net income 2024 | 17.04B 109M 149M | Net income 2025 * | 81.86B 524M 718M | EV / Sales 2024 | 1.63 x |
Net Debt 2024 | 336B 2.15B 2.94B | Net Debt 2025 * | 479B 3.07B 4.2B | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 |
173
x | P/E ratio 2025 * |
34.9
x | Employees | 14,484 |
Yield 2024 |
4.26% | Yield 2025 * |
4.7% | Free-Float | 98.84% |
Latest transcript on Astellas Pharma Inc.
1 day | +1.69% | ||
1 week | +6.01% | ||
Current month | +4.28% | ||
1 month | +1.89% | ||
3 months | -5.28% | ||
6 months | -15.59% | ||
Current year | -14.03% |
Managers | Title | Age | Since |
---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 61 | 86-03-31 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 52 | 10-31 |
Kenji Yasukawa
CHM | Chairman | 64 | 86-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takashi Tanaka
BRD | Director/Board Member | 67 | 21-05-31 |
Mamoru Sekiyama
BRD | Director/Board Member | 74 | 17-05-31 |
Naoki Okamura
CEO | Chief Executive Officer | 61 | 86-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 10.23 | +1.69% | 440,701 |
24-06-04 | 10.06 | +1.62% | 691,459 |
24-06-03 | 9.9 | +0.92% | 313,426 |
24-05-31 | 9.81 | +1.24% | 508,631 |
24-05-30 | 9.69 | +0.41% | 628,777 |
Delayed Quote OTC Markets, June 05, 2024 at 03:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.69% | 749B | |
+38.79% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.66% | 248B | |
-2.54% | 214B | |
+11.29% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- 4503 Stock
- ALPMY Stock